Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).

@article{Kudo2016ResponseEC,
  title={Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).},
  author={Masatoshi Kudo and Kazuomi Ueshima and Shoji Kubo and Michiie Sakamoto and Masatoshi Tanaka and Iwao Ikai and Junji Furuse and Takamichi Murakami and Masumi Kadoya and Norihiro Kokudo},
  journal={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2016},
  volume={46 1},
  pages={
          3-9
        }
}
The Response Evaluation Criteria in Solid Tumors (RECIST) is inappropriate to assess the direct effects of treatment on hepatocellular carcinoma (HCC) by locoregional therapies such as radiofrequency ablation (RFA) and transarterial chemoembolization (TACE). Therefore, establishment of response evaluation criteria solely devoted to HCC is needed urgently in clinical practice as well as in clinical trials of HCC treatment, such as molecular-targeted therapies, which cause necrosis of the tumor… CONTINUE READING